SAN

77.59

+1.09%↑

ARGX

707

+2.76%↑

SHL.DE

34.48

+0.5%↑

FRE

-0.4%↓

PHIA

23.2

+0.91%↑

SAN

77.59

+1.09%↑

ARGX

707

+2.76%↑

SHL.DE

34.48

+0.5%↑

FRE

-0.4%↓

PHIA

23.2

+0.91%↑

SAN

77.59

+1.09%↑

ARGX

707

+2.76%↑

SHL.DE

34.48

+0.5%↑

FRE

-0.4%↓

PHIA

23.2

+0.91%↑

SAN

77.59

+1.09%↑

ARGX

707

+2.76%↑

SHL.DE

34.48

+0.5%↑

FRE

-0.4%↓

PHIA

23.2

+0.91%↑

SAN

77.59

+1.09%↑

ARGX

707

+2.76%↑

SHL.DE

34.48

+0.5%↑

FRE

-0.4%↓

PHIA

23.2

+0.91%↑

Home・Aktien・Vetoquinol SA

Vetoquinol SA

Geschlossen

BrancheGesundheitswesen

72.2 1.12

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

70.5

Max

72.7

Schlüsselkennzahlen
By Trading Economics
Einkommen	7.2M 32M
Verkäufe	10M 268M
KGV Branchendurchschnitt	14.494 49.701
Dividendenrendite	1.31
Gewinnspanne	12.043
Angestellte	2,497
EBITDA	252M 301M

Empfehlungen
By TipRanks
Empfehlungen	Buy
12-Monats-Prognose	+52.14% upside

Dividenden
By Dow Jones
Dividendenrendite Branchendurchschnitt	1.31% 2.39%

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-102M 832M
Vorheriger Eröffnungskurs	71.08
Vorheriger Schlusskurs	72.2

Nachrichtenstimmung

By Acuity

50%

159 / 345 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Bearish Evidence

72.6 / 75.1 Unterstützung & Widerstand

Vetoquinol SA Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

20. Mai 2026, 23:31 UTC

Heiße Aktien

Stocks to Watch: Intuit, Applied Digital, Osisko, Banzai

20. Mai 2026, 22:52 UTC

Wichtige Markttreiber

Osisko Shares Fall on Planned Convertible Notes Offering

20. Mai 2026, 23:47 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

20. Mai 2026, 23:47 UTC

Market Talk

Nikkei May Rise on Continued AI Enthusiasm -- Market Talk

20. Mai 2026, 23:44 UTC

Ergebnisse

Musk Is In Total Control of SpaceX. The IPO Filing Has Finally Come. -- Barrons.com

20. Mai 2026, 23:35 UTC

Market Talk

Gold Edges Lower Amid Slightly Higher U.S. Treasury Yields -- Market Talk

20. Mai 2026, 23:30 UTC

Market Talk

Goodman Well-Placed for Earnings Guidance Upgrade -- Market Talk

20. Mai 2026, 23:17 UTC

Market Talk

Global Equities Roundup: Market Talk

20. Mai 2026, 23:17 UTC

Market Talk

Ryman Healthcare Bull Focusing on Three Areas in FY26 Result -- Market Talk

20. Mai 2026, 23:15 UTC

Market Talk

Mainfreight's FY26 Profit Fall May Mask Improving Performance -- Market Talk

20. Mai 2026, 23:14 UTC

Ergebnisse

Nvidia Rides Blistering Chip Sales to Another Record Quarter -- 4th Update

20. Mai 2026, 23:02 UTC

Market Talk

KMD Brands Faces Two Testing Hurdles -- Market Talk

20. Mai 2026, 22:57 UTC

Market Talk

Infratil's Other Assets Deserve Attention, Too -- Market Talk

20. Mai 2026, 22:57 UTC

Market Talk

Global Energy Roundup: Market Talk

20. Mai 2026, 22:57 UTC

Market Talk

Global Equities Roundup: Market Talk

20. Mai 2026, 22:51 UTC

Market Talk

Australia Shares Set to Rise, Continue Whipsaw Week -- Market Talk

20. Mai 2026, 22:51 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

20. Mai 2026, 22:27 UTC

Market Talk

SpaceX Says It Has Largest Addressable Market in 'Human History' -- Market Talk

20. Mai 2026, 22:14 UTC

Market Talk

Moody's Downgrades Mexico's Sovereign Rating -- Market Talk

20. Mai 2026, 22:10 UTC

Ergebnisse

Nvidia Rides Blistering Chip Sales to Another Record Quarter -- 3rd Update

20. Mai 2026, 22:00 UTC

Ergebnisse

Intuit Stock Falls on Earnings -- and the Company Plans to Cut 17% of Its Workforce -- Barrons.com

20. Mai 2026, 21:38 UTC

Ergebnisse

Akquisitionen, Fusionen, Übernahmen

Nvidia Rides Blistering Chip Sales to Another Record Quarter -- 2nd Update

20. Mai 2026, 21:27 UTC

Ergebnisse

Nvidia Rides Blistering Chip Sales to Another Record Quarter -- Update

20. Mai 2026, 21:20 UTC

Ergebnisse

Nvidia CFO: Edge Computing Demand Fell Modestly Due to Higher Memory Prices

20. Mai 2026, 21:19 UTC

Ergebnisse

Nvidia Still Uncertain Whether Shipping to China Will Be Allowed, CFO Says

20. Mai 2026, 21:18 UTC

Ergebnisse

Nvidia on Track to Start Production Shipments of Vera Rubin in Second Half of This Year, CFO Says

20. Mai 2026, 21:17 UTC

Ergebnisse

Nvidia Projects $20B in CPU Revenue This Year, CFO Says

20. Mai 2026, 21:17 UTC

Ergebnisse

Nvidia CFO: Every Major Hyperscaler Engaged in Deploying Vera CPU

20. Mai 2026, 21:17 UTC

Ergebnisse

Nvidia's Vera CPU Opens New $200B Market, CFO Says

20. Mai 2026, 21:16 UTC

Ergebnisse

SpaceX IPO Filing Finally Comes. Mars, Musk, and More Big Things to Watch. -- Barrons.com

Peer-Vergleich

Kursveränderung

Vetoquinol SA Prognose

Kursziel

By TipRanks

52.14% Vorteil

12-Monats-Prognose

Durchschnitt 110 EUR 52.14%

Hoch 110 EUR

Tief 110 EUR

Basierend auf 1 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Vetoquinol SA – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

1 ratings

Buy

Halten

Sell

Basierend auf 1 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Vetoquinol SA – Dist abgegeben haben.

Technischer Score

By Trading Central

72.6 / 75.1Unterstützung & Widerstand

Recent bearish events outweigh bullish events.

All events are bearish.

Stimmung

By Acuity

159 / 345 Ranking in Gesundheitswesen

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Vetoquinol SA

Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs, poultry, dogs, cats, and horses. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.